title: Intravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis.
abstract: Antigen presenting cells (APCs) play an important role in arthritis and APC specific gene therapeutic targeting will enable intracellular modulation of cell activity. Viral mediated overexpression is a potent approach to achieve adequate transgene expression levels and lentivirus (LV) is useful for sustained expression in target cells. Therefore, we studied the feasibility of lentiviral mediated targeting of APCs in experimental arthritis. Third generation VSV-G pseudotyped self-inactivating (SIN)-LV were injected intravenously and spleen cells were analyzed with flow cytometry for green fluorescent protein (GFP) transgene expression and cell surface markers. Collagen-induced arthritis (CIA) was induced by immunization with bovine collagen type II in complete Freund's adjuvant. Effect on inflammation was monitored macroscopically and T-cell subsets in spleen were analyzed by flow cytometry. Synovium from arthritic knee joints were analyzed for proinflammatory cytokine expression. Lentiviruses injected via the tail vein preferentially infected the spleen and transduction peaks at day 10. A dose escalating study showed that 8% of all spleen cells were targeted and further analysis showed that predominantly Ly6C+ and F4/80+ cells in spleen were targeted by the LV. To study the feasibility of blocking TAK1-dependent pathways by this approach, a catalytically inactive mutant of TAK1 (TAK1-K63W) was overexpressed during CIA. LV-TAK1-K63W significantly reduced incidence and arthritis severity macroscopically. Further histological analysis showed a significant decrease in bone erosion in LV-TAK1-K63W treated animals. Moreover, systemic Th17 levels were decreased by LV-TAK1-K63W treatment in addition to diminished IL-6 and KC production in inflamed synovium. In conclusion, systemically delivered LV efficiently targets monocytes and macrophages in spleen that are involved in autoimmune arthritis. Moreover, this study confirms efficacy of TAK1 targeting in arthritis. This approach may provide a valuable tool in targeting splenic APCs, to unravel their role in autoimmune arthritis and to identify and validate APC specific therapeutic targets.
authors: Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
authors: Ben T
authors: BT
authors: van den Brand
authors: Eline A
authors: EA
authors: Vermeij
authors: Claire E J
authors: CE
authors: Waterborg
authors: Onno J
authors: OJ
authors: Arntz
authors: Michael
authors: M
authors: Kracht
authors: Miranda B
authors: MB
authors: Bennink
authors: Wim B
authors: WB
authors: van den Berg
authors: Fons A J
authors: FA
authors: van de Loo
mesh_terms: D000818:Animals; D000943:Antigens, Differentiation / Q000235:genetics / Q000276:immunology; D000950:Antigens, Ly / Q000235:genetics / Q000276:immunology; D001169:Arthritis, Experimental / Q000139:chemically induced / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D015551:Autoimmunity; D024043:Collagen Type II; D016207:Cytokines / Q000096:biosynthesis / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology* / Q000473:pathology; D015870:Gene Expression; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins; D006678:HIV / Q000235:genetics; D007275:Injections, Intravenous; D020930:MAP Kinase Kinase Kinases / Q000235:genetics / Q000276:immunology; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D013154:Spleen / Q000276:immunology* / Q000473:pathology; D013582:Synovial Fluid / Q000737:chemistry; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000473:pathology; D014161:Transduction, Genetic; D019076:Transgenes; D000099151:MAP Kinase Kinase Kinase 7
chemical_list: D000943:Antigens, Differentiation; D000950:Antigens, Ly; D024043:Collagen Type II; D016207:Cytokines; D049452:Green Fluorescent Proteins; D020930:MAP Kinase Kinase Kinases; D000099151:MAP Kinase Kinase Kinase 7; C494192:Ly-6C antigen, mouse; C036763:monocyte-macrophage differentiation antigen
references: J Immunol. 2009 Nov 15;183(10):6733-43
references: 19864592
references: Blood. 2002 Aug 1;100(3):813-22
references: 12130491
references: Blood. 2010 Nov 4;116(18):3505-16
references: 20682854
references: PLoS One. 2012;7(2):e31550
references: 22348103
references: Blood. 2007 Sep 15;110(6):1788-96
references: 17495135
references: Immunity. 2012 Jan 27;36(1):43-54
references: 22226633
references: Eur J Immunol. 1995 Jan;25(1):200-6
references: 7843232
references: Arthritis Rheum. 2008 Nov;58(11):3461-70
references: 18975337
references: Arthritis Res Ther. 2010;12(2):R61
references: 20370892
references: Blood. 2007 Dec 15;110(13):4144-52
references: 17726165
references: Int J Radiat Biol. 2009;85(10):860-71
references: 19639504
references: J Control Release. 2011 Jun 30;152(3):363-9
references: 21396411
references: J Immunol Methods. 2008 May 20;334(1-2):70-81
references: 18367204
references: Arthritis Rheum. 2008 Dec;58(12):3742-52
references: 19035473
references: Hum Gene Ther. 2002 Jan 20;13(2):243-60
references: 11812281
references: Blood. 2004 May 15;103(10):3700-9
references: 14701690
references: Arthritis Res Ther. 2012 Jul 25;14(4):R173
references: 22830570
references: Mol Ther. 2009 Sep;17(9):1643-50
references: 19584812
references: J Leukoc Biol. 2009 Jun;85(6):919-27
references: 19304896
references: Immunology. 2006 Jan;117(1):22-8
references: 16423037
references: Mol Ther. 2007 Jul;15(7):1390-9
references: 17505480
references: Eur J Immunol. 2010 Jul;40(7):1830-5
references: 20583029
references: Arthritis Res Ther. 2010;12(4):R147
references: 20642832
references: Mol Ther. 2009 Apr;17(4):632-40
references: 19174762
references: Science. 2009 Jul 31;325(5940):612-6
references: 19644120